8-K: U.S. Physical Therapy Reports Record Patient Volume and Provides 2025 Earnings Guidance

U.S. Physical Therapy, Inc. (USPH) announces its fourth quarter and full year 2024 results, highlighting record quarterly patient volume and providing earnings guidance for 2025.

Summary

• U.S. Physical Therapy (USPH) reported its financial results for the three months and year ended December 31, 2024.
• Adjusted EBITDA for 2024 was $81.8 million, an increase of $3.9 million from 2023.
• Operating Results for 2024 were $36.9 million, up from $36.4 million in 2023, but decreased on a per share basis due to an increase in outstanding shares.
• USPH Net Income for 2024 was $31.4 million, compared to $28.2 million in 2023, which included charges related to clinic closures and asset impairments.
• Earnings per share for 2024 were $1.84, compared to $1.28 for 2023.
• For the fourth quarter of 2024, Adjusted EBITDA was $21.8 million, compared to $19.0 million for the same period in 2023.
• Fourth quarter Operating Results were $7.8 million, or $0.51 per share, compared to $8.9 million, or $0.59 per share, in the fourth quarter of 2023.
• USPH Net Income for the fourth quarter was $9.2 million, compared to $0.7 million for the same period in 2023.
• Total revenue from physical therapy operations for the fourth quarter increased by 14.2% to $153.8 million.
• The net rate per patient visit for the fourth quarter increased by 1.0% to $104.73.
• Average daily patient visits per clinic reached a record high of 31.7 in the fourth quarter.
• Industrial injury prevention services (IIP) revenue for the fourth quarter increased by 32.1% to $26.6 million.
• The company added 70 clinics and closed 2 during the fourth quarter, bringing the total to 768.
• The company acquired a 50% equity interest in a management services organization and a 75% equity interest in an eight-clinic practice.
• The board of directors increased the quarterly dividend from $0.44 to $0.45 per share.
• Management expects Adjusted EBITDA for 2025 to be in the range of $88 million to $93 million.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. The company reports increased revenue, EBITDA, and patient volume, and provides positive guidance for 2025. However, there are some concerns about rising costs and the impact of Medicare reimbursement reductions.

Positives

• Adjusted EBITDA increased year-over-year, reaching $81.8 million in 2024.
• Net income attributable to USPH shareholders increased to $31.4 million in 2024.
• Record quarterly patient volume was achieved, with 31.7 average daily visits per clinic in Q4 2024.
• Total revenue from physical therapy operations increased by 14.2% in Q4 2024.
• Industrial injury prevention services (IIP) revenue increased by 32.1% in Q4 2024.
• The company expanded its clinic network by adding 70 clinics in Q4 2024.
• The quarterly dividend was increased to $0.45 per share.
• Management expects Adjusted EBITDA for 2025 to be in the range of $88 million to $93 million.
• Net rate per patient visit increased to $104.73 in Q4 2024.

Negatives

• Operating Results decreased on a per share basis due to an increase in outstanding shares from a secondary offering.
• The 2024 year includes a $1.0 million true-up of income tax expense.
• Gross profit margin from physical therapy operations decreased from 19.5% to 17.9% in Q4 2024.
• Salaries and related costs per visit increased to $63.00 in Q4 2024 from $59.72 in Q4 2023.
• Total operating costs per visit increased to $86.72 in Q4 2024 from $84.09 in Q4 2023.
• Cash and cash equivalents decreased significantly from $152.8 million to $41.4 million due to acquisitions.

Risks

• Changes in Medicare rules and reimbursement rates could negatively impact revenue.
• Competition and economic conditions in the markets served could require clinic reorganization or closure.
• The company's debt and financial obligations could adversely affect its financial condition.
• Failure to identify and complete acquisitions or successfully integrate acquired businesses could hinder growth.
• Cybersecurity breaches could lead to legal action and reputational harm.
• The company's business depends on hiring and retaining qualified employees, and a shortage of physical therapists could impact operations.
• The Medicare rate reduction of approximately 2.9% effective January 1, 2025, is expected to reduce the Company's revenue by approximately $6.5 million for the full year 2025.

Future Outlook

Management expects Adjusted EBITDA for 2025 to be in the range of $88 million to $93 million, anticipating growth from acquisitions, rate negotiations, volume increases, and the industrial injury prevention business.

Management Comments

• Chris Reading, Chief Executive Officer, noted the challenges faced by the industry due to Medicare reimbursement reductions and rising costs.
• He highlighted the team's efforts to grow volume, rate, and profit despite these headwinds.
• Reading mentioned ongoing initiatives to improve cost and labor efficiency.
• He expects 2025 to be a solid growth year supported by these initiatives, record demand, rate increases, and recent acquisitions.

Industry Context

The physical therapy industry has faced challenges due to Medicare reimbursement reductions and rising costs, impacting profitability. USPH is focused on growth through acquisitions, rate negotiations, and volume increases to navigate these challenges. The company's expansion into industrial injury prevention services diversifies its revenue streams and aligns with the growing emphasis on workplace safety and employee well-being.

Comparison to Industry Standards

• USPH's focus on outpatient physical therapy clinics and industrial injury prevention services aligns with industry trends towards integrated care models.
• Companies like ATI Physical Therapy and Select Medical also operate large networks of outpatient clinics, but USPH's emphasis on partnership models with physicians and therapists differentiates its approach.
• The company's Adjusted EBITDA margin of approximately 12.2% ($81.8 million/$671.3 million) for 2024 is comparable to industry averages for publicly traded rehabilitation companies.
• USPH's growth strategy of acquiring multi-clinic practices and developing satellite clinics is consistent with industry consolidation trends.
• The company's investment in industrial injury prevention services reflects a broader trend towards preventative care and workplace wellness programs.

Stakeholder Impact

• Shareholders will benefit from the increased dividend and potential for future growth.
• Employees may see opportunities for advancement as the company expands its operations.
• Patients will have access to a wider network of clinics and services.
• Suppliers may see increased demand for their products and services.
• Creditors will be reassured by the company's strong financial performance and positive outlook.

Next Steps

• Management will host a conference call on February 27, 2025, to discuss the financial results.
• The company expects to file its Annual Report on Form 10-K with the SEC on March 3, 2025.
• The company will continue to focus on acquisitions, rate negotiations, and volume increases to achieve its 2025 Adjusted EBITDA guidance.
• The company will pay a quarterly dividend of $0.45 per share on April 11, 2025, to shareholders of record on March 14, 2025.

Key Dates